Bristol-Myers Squibb has signed an agreement worth $475 million to develop a new form of cancer immunotherapy drug with US biotech Dragonfly Therapeutics. BMS is best known as an early pioneer of ...
Dragonfly Energy Holdings Corp. engages in the manufacturing and sale of deep cycle lithium-ion batteries for recreational vehicles, marine vessels, solar and off-grid residence industries, and ...
1 Day DFLI 5.73% DJIA -0.17% Russell 2K 0.12% Industrial Goods 0.99% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback